Sanofi Files 6-K on April 30th Annual Meeting
Ticker: SNYNF · Form: 6-K · Filed: May 5, 2025 · CIK: 1121404
| Field | Detail |
|---|---|
| Company | Sanofi (SNYNF) |
| Form Type | 6-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: agm, filing-update
TL;DR
Sanofi filed a 6-K for its April 30th Annual General Meeting.
AI Summary
Sanofi filed a Form 6-K on May 5, 2025, reporting on its Annual General Meeting held on April 30, 2025. The filing includes a press release from April 30, 2025, which is incorporated by reference.
Why It Matters
This filing provides shareholders with information regarding decisions and discussions from Sanofi's Annual General Meeting, which can impact company strategy and governance.
Risk Assessment
Risk Level: low — This is a routine filing reporting on a past event (Annual General Meeting) and does not contain new financial or strategic information that would typically alter risk.
Key Players & Entities
- Sanofi (company) — Registrant
- 001-31368 (company) — SEC File Number
- April 30, 2025 (date) — Annual General Meeting date
- May 5, 2025 (date) — Filing date
FAQ
What type of report is Sanofi filing?
Sanofi is filing a Form 6-K, which is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was the Annual General Meeting mentioned in the filing?
The Annual General Meeting was held on April 30, 2025.
What is incorporated by reference into this 6-K filing?
A press release dated April 30, 2025, titled 'Annual General Meeting of April 30, 2025', is incorporated by reference as Exhibit 99.1.
What is Sanofi's principal executive office address?
Sanofi's principal executive offices are located at 46, avenue de la Grande Armée, 75017 Paris, France.
Does Sanofi file annual reports under Form 20-F or Form 40-F?
Sanofi indicates that it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding Sanofi (SNYNF).